Basch R S, Kouri Y H, Karpatkin S
Department of Pathology, Kaplan Cancer Center, New York University Medical School, NY 10016.
Proc Natl Acad Sci U S A. 1990 Oct;87(20):8085-9. doi: 10.1073/pnas.87.20.8085.
The CD4 antigen, which serves as the receptor for human immunodeficiency virus type 1 (HIV-1) on T cells, has been detected on human megakaryocytes. Recent evidence of impaired thrombopoiesis in HIV-1-related thrombocytopenia suggested that these cells could be directly infected by the virus and prompted a search for a receptor on megakaryocytes of normal subjects that could permit entry of HIV-1. Bone marrow specimens from uninfected normal control subjects were centrifuged over Ficoll-Hypaque (1.077 g/ml) and analyzed by three-color analysis with a flow cytometer utilizing monoclonal antibodies against CD4 and a glycoprotein present on the surface of megakaryocytes and platelets (GPIIb/IIIa; CD41), as well as 7-aminoactinomycin D, a stain for DNA. Cells presumed to be megakaryocytes were identified by having a DNA content greater than tetraploid and staining brightly with anti-CD41. Approximately 0.4% of the nucleated cells of the marrow met these criteria. Twenty-five percent of these megakaryocytes stained as brightly as CD4+ T cells. Several clones of antibody recognizing different epitopes of the CD4 molecule gave similar results. Platelets were CD4-. Staining of megakaryocytes with anti-CD4 was confirmed by direct microscopic examination of Percoll-gradient-enriched megakaryocytes employing two-color (CD4-phycoerythrin and CD41-fluorescein) immunofluorescence analysis and phase-contrast microscopy. The proportion of double-labeled cells among 112 phase-contrast-identifiable megakaryocytes from five bone marrow specimens varied between 20% and 26% with a mean and SD of 22% +/- 2.5%. Thus some human megakaryocytes express CD4 on their surface that should be capable of binding the HIV-1 gp120 envelope protein. This could serve as a portal of entry for HIV-1.
CD4抗原是T细胞上人类免疫缺陷病毒1型(HIV-1)的受体,已在人类巨核细胞中被检测到。最近有证据表明,HIV-1相关性血小板减少症中血小板生成受损,提示这些细胞可能被该病毒直接感染,并促使人们寻找正常受试者巨核细胞上可允许HIV-1进入的受体。将未感染的正常对照受试者的骨髓标本在Ficoll-Hypaque(1.077 g/ml)上进行离心,并使用针对CD4以及存在于巨核细胞和血小板表面的一种糖蛋白(糖蛋白IIb/IIIa;CD41)的单克隆抗体,以及一种DNA染色剂7-氨基放线菌素D,通过流式细胞仪进行三色分析。通过DNA含量大于四倍体且抗CD41染色明亮来鉴定推测为巨核细胞的细胞。骨髓中有核细胞中约0.4%符合这些标准。这些巨核细胞中有25%的染色强度与CD4+ T细胞相同。几种识别CD4分子不同表位的抗体克隆给出了相似的结果。血小板为CD4阴性。通过使用双色(CD4-藻红蛋白和CD41-异硫氰酸荧光素)免疫荧光分析和相差显微镜对Percoll梯度富集的巨核细胞进行直接显微镜检查,证实了巨核细胞用抗CD4染色的结果。来自5份骨髓标本的112个相差显微镜可识别的巨核细胞中双标记细胞的比例在20%至26%之间,平均值和标准差为22%±2.5%。因此,一些人类巨核细胞在其表面表达CD4,这应该能够结合HIV-1 gp120包膜蛋白。这可能成为HIV-1的一个进入门户。